Abstract:Hirudin is the most potent natural inhibitor of thrombin and a powerful anticoagulant. Large-scale production of recombinant hirudin is desirable for therapy. In this study, the gene encoding hirudin variant III was redesigned and synthesized by usingBacillus subtilispreferred codons, and the recombinant hirudin variant III (rHV3) was overexpressed inB. subtilisDB403 with strong anticoagulation activity for the first time. The hirudin activity from the supernatant of culture with optimized expression conditions could reach 210 ATU/ml. The protein in culture supernatant was precipitated by trichloroacetic acid, then desalted by ultrafiltration and purified by anion exchange chromatography. Strong anion Q F.F. performed better than weak anion DEAE F.F. The proper pH and conductivity was determined at pH 8 and 6 ms/cm, respectively. The maximum applied sample was 240 ATU/ml to medium of strong anion Q F.F. This optimized procedure was employed in strong anion exchange HiPrep 16/10Q with the 90% recovery rate and 70.2% purity. After gel filtration, the purity of rHV3 checked by HPLC could reach 95.1%, and the recovery rate was 93% for this step. The purified recombinant rHV3 showed a single band in SDS-PAGE. The rHV3 was stable at 100 °C and acidity condition, but was unstable under the condition of both heating and alkalinity. In conclusion, theses studies suggests thatB.subtilismight be useful for the production of biologically active medicine peptides in secretion facilitating purification procedures, and that this isolation method was suitable for scale-up purification process at a low cost.

Studies on the Freeze Drying Technology and Thermal Stability of Recombinant Hirudin from Bacillus Subtilis

Studies on the Separation and Purification of Recombinant Hirudin Variant 3 from the Bacillus Subtilis

Expression, Purification and Characterization of the Recombinant Hirudin Variant Iii in the Bacillus Subtilis

Preliminary Study on the Freeze-Drying of Human Bone Marrow-Derived Mesenchymal Stem Cells

Preparation of Hirudin Gelatin Microsphere and Its Evaluation of Release in Vitro

Optimization of lyoprotectant for recombinant human acidic fibroblast growth factor by response surface methodology

Simple and Efficient Methods for Isolation and Activity Measurement of the Recombinant Hirudin Variant 3 from Bacillus Subtilis

重组hIFN-α-2b-BCG的冻干制备及生物特性的研究

Refolding and two-step purification by hydrophobic interaction chromatography of recombinant human bone morphogenetic protein-2 from Escherichia coli

High-Level Expression and Purification of Recombinant Heparinase Ⅰ in Escherichia Coli

[Fermentation, Purification and Identification of Recombinant RGD-Hirudin].

Stabilization of a recombinant human epidermal growth factor parenteral formulation through freeze-drying

Progress and Prospect of Hirudin and Its Derivants Research

Controlled Delivery of Recombinant Hirudin Based on Thermo-Sensitive Pluronic® F127 Hydrogel for Subcutaneous Administration: in Vitro and in Vivo Characterization

Construction, Expression, and Characterization of Recombinant Hirudin in Escherichia Coli.

A development of LC-MS method combining ultrafiltration and lyophilization for determination of r-RGD-Hirudin in human serum.

The study of the fermentation conditions and purification of recombinant HBD-2

Effect of Different Protectants on Freeze-Drying and 100℃ Dry-Heat Inactivation of Human Coagulation Factor Ⅷ

Freeze-Drying of Plant Tissue Containing HBV Surface Antigen for the Oral Vaccine against Hepatitis B

Synthesis of Hirudin Gene by Recursive PCR and Its Expression and Secretion in Escherichia Coli

Response Surface Optimization of Lyoprotectant from Amino Acids and Salts for Bifidobacterium Bifidum During Vacuum Freeze-Drying